Source: Startupticker

Anaveon: Seasoned chairpersons and board members back life sciences startups

Immuno-oncology company Anaveon and LimmaTech Biologics, which develops vaccines for the prevention of life-threatening diseases have appointed industry experts to lead their Boards of Directors. For Onde, provider of root canal treatments, the newly welcomed member of the board will support the company's US expansion.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Andreas Katopodis's photo - Co-Founder & CEO of Anaveon

Co-Founder & CEO

Andreas Katopodis

CEO Approval Rating

90/100

Read more